| 000 | 01626 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515193638.0 | ||
| 264 | 0 | _c20100422 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1555-2101 | ||
| 024 | 7 |
_a10.4088/JCP.08m04818yel _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaandrup, Lone | |
| 245 | 0 | 0 |
_aAntipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study. _h[electronic resource] |
| 260 |
_bThe Journal of clinical psychiatry _cFeb 2010 |
||
| 300 |
_a103-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCause of Death _xtrends |
| 650 | 0 | 4 | _aDenmark |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aGasse, Christiane | |
| 700 | 1 | _aJensen, Vibeke D | |
| 700 | 1 | _aGlenthoj, Birte Y | |
| 700 | 1 | _aNordentoft, Merete | |
| 700 | 1 | _aLublin, Henrik | |
| 700 | 1 | _aFink-Jensen, Anders | |
| 700 | 1 | _aLindhardt, Anne | |
| 700 | 1 | _aMortensen, Preben B | |
| 773 | 0 |
_tThe Journal of clinical psychiatry _gvol. 71 _gno. 2 _gp. 103-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4088/JCP.08m04818yel _zAvailable from publisher's website |
| 999 |
_c19283511 _d19283511 |
||